ReWalk Robotics, Maker Of The Exoskeleton For Paraplegics, Updates IPO Terms for $50M

The ReWalk Robotics, the Israeli creator of the recently FDA-approved exoskeletons that enable paraplegics to walk, has released the terms for its IPO. The company plans to raise $50 million by offering 3.4 million shares at a $14 to $16 price range. ReWalk Robotics would command a fully diluted market value of $191 million, which is lower than former predictions. The company, founded in 2001, has marketed the product in hospitals earning $1.6 million revenue in 2013 and a loss of $12.2 million.